Navigation Links
EnVivo Pharmaceuticals Announces Executive Appointment
Date:9/26/2007

Dr. Dana C. Hilt Named SVP, Clinical Development & Chief Medical Officer

WATERTOWN, Mass., Sept. 26 /PRNewswire/ -- EnVivo Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs for neurodegenerative diseases, today announced the appointment of Dr. Dana C. Hilt as Senior Vice President and Chief Medical Officer. He will be responsible for coordinating all pre-clinical and clinical development activities of EnVivo's growing pipeline.

Dr. Hilt, 55, previously served as Senior Vice President, Clinical Research and Medical Affairs & Chief Medical Officer for Critical Therapeutics in Lexington, Massachusetts. Dr. Hilt is a distinguished neurologist with extensive drug development experience from his tenures at Amgen, Guilford Pharmaceuticals and Ascend Therapeutics. In addition, he has held both scientific and professorial positions with the University of Southern California School of Medicine, the National Institutes of Health and the University of Maryland School of Medicine where he was a clinical Associate Professor in the department of Neurology. At the beginning of his career, he was a Resident Fellow in Neurology at the Johns Hopkins University School of Medicine and interned at Harvard University Medical School.

Dr. Hilt is a member of the American Academy of Neurology, Movement Disorders Society, American Society for Experimental Neurotherapeutics, American Association for the Advancement of Science, Society for Neuroscience and Endocrine Society. He is the author of over 50 publications. Dr. Hilt received his Bachelor of Science Degree in Chemistry (with Distinction) from the University of Maine and an M.D. from the Tufts University School of Medicine.

"Given the continuing growth of EnVivo's pre-clinical and clinical programs in the field of neuro-degenerative diseases, Dana brings critically important skills to the management team. His deep expertise in drug development will be of increasing importance
'/>"/>

SOURCE EnVivo Pharmaceuticals, Inc.,
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... 10 With the economy and markets exhibiting ... largest, fastest-growing small cap equity research provider, will seek ... opportunities within the micro cap market at the firm,s ... 11, 2010 at the Grand Hyatt Hotel in New ... overlooked and undervalued by much of Wall Street, but ...
(Date:12/10/2009)... Brooks Instrument, a world-leading provider of advanced flow ... Bayda will join the company as Global Level ... lead Brooks Instrument’s efforts to enhance market penetration ... He is joining Brooks Instrument from Lafarge Corp, ... as Director of Marketing and Sales. Bayda will ...
(Date:12/10/2009)... 10 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc.,(OTC Bulletin ... growing developer and,producer of prescription drugs and ... People,s Republic of China ("PRC"), today reported ... controlled operating entity of Lotus,appointed Mr. Jinzhong ... Company,s,Over-the-Counter Drug division ("OTC Division"). , ...
(Date:12/10/2009)... Dendreon Corporation (Nasdaq: DNDN ) today ... chief operating officer, effective January 4, 2010. Mr. ... medicine business at Bayer, where he was responsible for ... Mr. Bishop also served as an executive vice ... member of the Dendreon executive management team, Mr. Bishop ...
Breaking Biology Technology:Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3Dendreon Appoints Hans Bishop as Chief Operating Officer 2
... Silence Therapeutics plc (London AIM:,SLN), a leading ... reasons, Jeffery Vick has resigned as Group CEO ... has appointed Iain Ross, currently Non-Executive,Chairman, full time ... Cook, a Non-Executive Director of the Company has ...
... ,Hologic, Inc. (Nasdaq: HOLX ) and Third Wave ... expiration of the initial,offering period of the tender offer ... all outstanding shares of common stock of,Third Wave. The ... York City time, on Wednesday, July 16, 2008., ...
... on Strategies to Promote Legislative Pathway for ... Follow-On ... developer of follow-on biologics and biopharmaceuticals for unmet,medical needs, today announced ... Means Committee from 2001 to 2007, has been,retained by Insmed as ...
Other Biology Technology:Organizational Changes at Silence Therapeutics 2Organizational Changes at Silence Therapeutics 3Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period 2Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period 3Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period 4Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period 5Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor 2Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor 3Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor 4
(Date:12/14/2009)... sneezing, touching, or for Tasmanian devils biting ... have driven the dinosaurs to extinction through the transmission ... of f1000 Biology, highlights the ,paleobiological detective work, of ... led them to deduce that a protozoan parasite was ... many tyrannosaurid fossils. , The parasite,s modern-day equivalent, which ...
(Date:12/14/2009)... team of researchers from the Astrobiology Centre (INTA-CSIC) has ... essential to the formation of the most basic biological ... In order to carry out this study, published in ... recreated the chemical conditions of the early Earth. , ... in ammoniac solutions it produces hydrogen cyanide, a substance ...
(Date:12/14/2009)... in preventing some of the stresses of open surgery on ... and organ dysfunction. Laparoscopy is a type of surgery in ... , By adding another gas to the carbon dioxide used ... University Medical Center have found they can preserve more normal ... nitrite (ENO) helped to open blood vessels and keep blood ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2Gas improves blood flow and organ status during minimally invasive surgery 2Cardiogenesis Reports Third Quarter 2009 Results 6149 1Cardiogenesis Reports Third Quarter 2009 Results 6149 2Cardiogenesis Reports Third Quarter 2009 Results 6149 3Cardiogenesis Reports Third Quarter 2009 Results 6149 4Cardiogenesis Reports Third Quarter 2009 Results 6149 5Cardiogenesis Reports Third Quarter 2009 Results 6149 6Cardiogenesis Reports Third Quarter 2009 Results 6149 7Neuro Kinetics Statement Concerning Newspaper Article 6147 1Neuro Kinetics Statement Concerning Newspaper Article 6147 2Neuro Kinetics Statement Concerning Newspaper Article 6147 3Vion Pharmaceuticals Reports 2009 Third Quarter and Nine Month Results 6145 1Vion Pharmaceuticals Reports 2009 Third Quarter and Nine Month Results 6145 2Vion Pharmaceuticals Reports 2009 Third Quarter and Nine Month Results 6145 3Vion Pharmaceuticals Reports 2009 Third Quarter and Nine Month Results 6145 4Vion Pharmaceuticals Reports 2009 Third Quarter and Nine Month Results 6145 5Vion Pharmaceuticals Reports 2009 Third Quarter and Nine Month Results 6145 6
... Census of Marine Life-affiliated scientists consolidating world databases ... almost one-third of all names culled from 34 ... World Register of Marine Species ( www.marinespecies.org ) ... having recognized and tidied up some 56,400 aliases ...
... professor of psychology at UC Santa Barbara and director ... Mind, has received the Humboldt Research Prize in recognition ... a true pioneer in reaching across the disciplines to ... and brain," said UCSB Chancellor Henry T. Yang. "The ...
... growing up in Brooklyn, NY, UC Riverside,s Jerome Schultz ... to peer into a microscope to examine slides of tissues ... years, that early interest in science evolved into an illustrious ... that the American Institute of Chemical Engineers ( AIChE ...
Other Biology News:Census of Marine Life lists 122,500 known species, over halfway to complete inventory by Oct. 2010 2Census of Marine Life lists 122,500 known species, over halfway to complete inventory by Oct. 2010 3Census of Marine Life lists 122,500 known species, over halfway to complete inventory by Oct. 2010 4Census of Marine Life lists 122,500 known species, over halfway to complete inventory by Oct. 2010 5Neuroscientist Michael Gazzaniga awarded Humboldt Prize 2UC Riverside bioengineer receives high honor from chemical engineers 2UC Riverside bioengineer receives high honor from chemical engineers 3UC Riverside bioengineer receives high honor from chemical engineers 4
Mouse monoclonal [7E10] to C Peptide ( Abpromise for all tested applications). entrezGeneID: 3630 SwissProtID: P01308...
Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide...
... Recognizes Nabeta2. The epitope specific ... in any other known proteins.,SPECIES ... to work on human because ... conserved (17/19 residues). Reactivity with ...
Goat polyclonal to JIK ( Abpromise for all tested applications). Antigen: Synthetic peptide: HKKDHVFIRDEAGHGD, corresponding to amino acids 396-411 of Human JIK. Entrez Gene ID: 51347 Swi...
Biology Products: